Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis
Linezolid ADRs were frequent in a high-resource setting. Structured, regular follow-up for ADRs and adjusting dosing according to body weight followed-up by monitoring of drug concentrations early may reduce toxicity.
Authors
- Jan‐Willem C. Alffenaar (ORCID: https://orcid.org/0000-0001-6703-0288)
- Thomas Schön (ORCID: https://orcid.org/0000-0003-4849-1286)
- Johanna Kuhlin (ORCID: https://orcid.org/0000-0002-3398-2421)
- Ramona Groenheit (ORCID: https://orcid.org/0000-0003-2696-437X)
- Jerker Jonsson (ORCID: https://orcid.org/0000-0003-1383-6176)
- Judith Bruchfeld (ORCID: https://orcid.org/0000-0001-5399-0982)
- Mikael Mansjö (ORCID: https://orcid.org/0000-0001-9289-351X)
- Jim Werngren (ORCID: https://orcid.org/0000-0003-2500-9792)
- Lina Davies Forsman (ORCID: https://orcid.org/0000-0001-8885-3320)
- Aisha Osman (ORCID: https://orcid.org/0000-0002-5015-6316)
- Magdalena Skagerberg
Institutions
- Linköping University (SE)
- The University of Sydney (AU)
- Public Health Agency of Sweden (SE)
- Karolinska University Hospital (SE)
- Sydney Hospital (AU)
- Karolinska Institutet (SE)
- Linköping University Hospital (SE)
Publication Details
- Journal
- International Journal of Antimicrobial Agents
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1016/j.ijantimicag.2024.107302
- Citations
- 9
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 3.50
Funders
- Hjärt-Lungfonden
- Vetenskapsrådet